DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer
Open Access
- 15 September 1994
- Vol. 74 (6) , 1752-1761
- https://doi.org/10.1002/1097-0142(19940915)74:6<1752::aid-cncr2820740618>3.0.co;2-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Consensus review of the clinical utility of dna cytometry in carcinoma of the breastCytometry, 1993
- Improved Flow Cytometric Determination of Proliferative Activity (S-phase fraction) from Paraffin-Embedded TissueAmerican Journal of Clinical Pathology, 1990
- The Importance of DNA Flow Cytometry in Node-Negative Breast CancerArchives of Surgery, 1990
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988
- DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breastBritish Journal of Cancer, 1987
- Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.Journal of Histochemistry & Cytochemistry, 1983